Sign in
4

Changes in Ownership

Hims & Hers Health, Inc. Filed Acc 0001773751-25-000051

Chief Executive Officer sold 175,661 shares at an average $58.24 ($10,230,063)

  • Chief Executive Officer acquired 125,335 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dudum Andrew · Chief Executive Officer

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-18 Sale : show line 1 in the form 10b5-1 −1,992 $58.35 $116,225 98,487 D
2025-02-18 Sale : show line 2 in the form 10b5-1 −800 $59.69 $47,751 97,687 D
2025-02-18 Exercise or conversion : show line 3 in the form 10b5-1 +17,001 $2.43 $41,312 114,688 D
2025-02-18 Exercise or conversion : show line 4 in the form 10b5-1 +108,334 $2.43 $263,252 223,022 D
2025-02-18 Sale : show line 5 in the form 10b5-1 −33,347 $57.86 $1,929,447 189,675 D
2025-02-18 Sale : show line 6 in the form 10b5-1 −81,660 $58.26 $4,757,430 108,015 D
2025-02-18 Sale : show line 7 in the form 10b5-1 −10,328 $59.57 $615,268 97,687 D
2025-02-18 Sale : show line 8 in the form 10b5-1 −14,784 $57.85 $855,293 460,546 I
2025-02-18 Sale : show line 9 in the form 10b5-1 −31,257 $58.22 $1,819,754 429,289 I
2025-02-18 Sale : show line 10 in the form 10b5-1 −1,493 $59.54 $88,895 427,796 I
Open-market sales · 175,661 sh · avg $58.24 · $10,230,063

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-02-18 Exercise or conversion : show line 11 in the form 10b5-1 Stock Option (right to buy) −17,001 $2.43 2030-06-17 17,001 153,013 D
2025-02-18 Exercise or conversion : show line 12 in the form 10b5-1 Stock Option (right to buy) −108,334 $2.43 2030-06-16 108,334 1,298,067 D
Loading xslF345X05/wk-form4_1740100674.xml…